|
Bafna Pharmaceuticals Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
248.04 Cr.
|
P/BV
|
2.92
|
Book Value (Rs.)
|
35.85
|
|
52 Week High/Low (Rs.)
|
115/69
|
FV/ML
|
10/1
|
P/E(X)
|
59.74
|
|
Bookclosure
|
25/09/2024
|
EPS (Rs.)
|
1.76
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | -1.88 | -18.29 | -14.72 | -20.37 | -15.32 |
| | | | | | |
| Net CashFlow From Operating Activities | -34.31 | -1.79 | -7.05 | -0.95 | 0.91 |
| Net Cash Used In Investing Activities | 32.77 | 14.93 | 37.97 | -5.42 | -0.36 |
| Net Cash Used From Financing Activities | 7.30 | -13.38 | -30.63 | 6.31 | -0.61 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 5.77 | -0.24 | 0.29 | -0.06 | -0.06 |
| Cash And Cash Equivalents Begin of Year | 2.71 | 2.95 | 2.66 | 2.71 | 2.77 |
| Cash And Cash Equivalents End Of Year | 8.48 | 2.71 | 2.95 | 2.66 | 2.71 |
